Matt Biegler

Stock Analyst at Oppenheimer

(n/a)
# 4,407
Out of 4,761 analysts
1
Total ratings
n/a
Success rate
-69.87%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Matt Biegler

OnKure Therapeutics
Oct 10, 2024
Initiates: Outperform
Price Target: $35
Current: $5.46
Upside: +541.03%